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Glomerular disease in hypercholesterolemic guinea pigs: A pathoge-
netic study. Recent evidence suggests a role for lipid deposition in the
pathogenesis of some forms of glomerular disease. To gain further
insight into this phenomenon guinea pigs (GP) were fed a 2% cholesterol
(HC) diet and compared to GP on a normal diet (C). Serial observations
were made 5, 10, 30 and 70 days after the initiation of the experiment.
HC gained less weight than C (P < 0.001) and developed hemolytic
anemia after 30 days. At all time periods serum total cholesterol (TC)
was significantly elevated in HC (P < 0.001). High density lipoprotein-
cholesterol and total phospholipids (FL) were significantly higher in HC
at days 30 and 70. Lipoprotein-X was detected in HC serum. The
relative proportion (%) of cholesteryl ester (CE) at day 70 was signifi-
cantly higher in HC than in C when renal cortical lipids were analyzed
(P < 0.017). Renal function was normal in both groups throughout the
70 days. The HC group developed proteinuria and hematuria (protein-
uria, HC = 22.1 7.2 mg/24 hr; C, 6.4 2.3 mg/24 hr), which was
detected at day 70 but not at day 30. HC developed significant
progressive mesangial expansion which was first evident at day 30. In
HC only oil red 0 material was first detected in glomeruli at day 5 and
was very conspicuous at day 70. Increased intraglomerular monocyte
numbers were detected at day 70 (P < 0.017) but not at day 30 in HC.
No glomerulosclerosis was observed in GP's with drug-induced hemo-
lysis on a normal diet. To see the effect of high protein intake on HC
GP's, a group of GP's was put on a HC diet for 30 days followed by a
2% cholesterol-high protein (ECUP) diet for 40 days. Compared to HC
GP's, the HCHP group showed significantly higher serum TC and PL (P
<0.017), mesangial expansion (P < 0.01) and proteinuria (P < 0.01).
The results indicate that hypercholesterolemia plays an important role
in the pathogenesis of glomerulosclerosis in this model and that the
process appears to be mediated, at least in part in the later stages, by
monocytes. The addition of protein to the HC diet augments these
effects.
The significance of lipid deposition in renal glomeruli and the
role of lipoproteins in the pathogenesis of renal disease is
unclear. Recent experimental evidence suggests that lipid may
have an important role in the development of some glomerular
lesions. The results of a study of long-term effects of aminonu-
cleoside and adriamycin in rats indicated an association be-
tween lipid deposition in the mesangium and the development
of focal and segmental hyalinosis and sclerosis [1]. Silva,
Edwards and Pirani have shown that aminonucleoside-induced
focal glomeruloscierosis is enhanced by a high fat diet, and
lowering of serum lipids by halofenate protects against this
Received for publication February 5, 1987
and in revised form June 23, 1987
© 1988 by the International Society of Nephrology
development [2]. Glomerulosclerosis develops in guinea pigs
(GP) rendered hypercholesterolemic on a 1% cholesterol diet
[3]. Kelley and Izui have demonstrated that an enriched lipid
diet results in increased lipid accumulation in glomeruli and
accelerated glomerular injury in NZBxW mice with lupus
nephritis compared to NZBxW animals on a normal diet [4]. In
genetically obese rats which develop focal glomeruloscierosis
[5—7] there is some evidence to suggest that lipid is involved in
the pathogenesis of this lesion [5, 6].
In humans glomerular lipid deposition is observed in Fabry's
disease [8], lecithin:cholesterol acyltransferase (LCAT) defi-
ciency [9], cholestatic liver disease [10] and arteriohepatic
dysplasia (Alagille's syndrome) [11]. The latter two diseases are
characterized by hypercholesterolemia, and renal dysfunction
is common in LCAT deficiency and arteriohepatic dysplasia.
Hyperlipidemia and lipoprotein abnormalities are also part of
the nephrotic syndrome of whatever cause [12] and uremia [13].
At physiological pH and ionic strength some lipoproteins can
bind with polyanionic glycosaminoglycans [14] which have
been demonstrated in glomerular basement membranes (GBM)
[15]. In view of this and the suggestion that lipoproteins may be
important in the maintenance of the GBM's structure and
permeability [16], Moorhead et al have postulated that abnor-
malities of lipoproteins may result in glomerular damage and
progressive renal disease [17].
Although the biochemical findings and glomerular lesions in
the hypercholesterolemic GP are well described [3, 18], the
evolution of the changes in glomerular structure over time and
the role, if any, of monocytes in the development of the
glomerular lesions have not been adequately documented. In
order to gain further insight into the pathogenetic mechanism(s)
involved in the development of glomeruloscierosis in the hyper-
cholesterolemic GP, we conducted a study involving sequential
biochemical, histochemical and morphological observations.
Because of the demonstration of a deleterious role of dietary
protein in several experimental models of renal disease [19—23],
the effect of a high protein diet on the course of the glomerular
disease in hypercholesterolemic GP's was also investigated.
The results document a significant relationship between serum
cholesterol level, renal tissue cholesterol level and glomerular
disease and suggest a role for monocytes in the development of
the glomerular lesion. Moreover, a high protein diet signifi-
cantly augments the glomerular disease produced by high
cholesterol intake.
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Table 1. Composition of the vanous diets used (g/100 g diet)a
Vitaminse
Carbohy- and Miner-
Diet Fatb Protein0 drate als Fiber
Normal (C) 7.3
High protein (HP) 4.0
30.0
50.0
38.1
30.0
6.0
6.0
15.0
7.0
a For the high cholesterol (HC) and high cholesterol-high protein
(HCHP) diets, 2 g cholesterolll00 g diet were added to the normal and
high protein diets, respectively.
b Corn oil
Casein
d Dextrose
The drinking water contained additional ascorbic acid at a concen-
tration of approximately 200 mg/liter
Cellulose
Methods
Experimental design
Seventy-eight 3-month-old, male Hartley English GP's, weigh-
ing approximately 330 to 370 grams were housed in individual
cages and allowed to acclimatize for one week, during which
time they were fed a normal diet (standard Reid Briggs diet
obtained from ICN Biochemicals, Montreal, P.Q.) and allowed
water ad lib. At the start of the experiment the animals were
divided into five groups. One group (N = 19) was fed a normal
diet (C) and a second (N = 28) was put on a standard diet
enriched with 2% cholesterol (by weight) (HC). A pilot study
had previously shown that GP's on a HC diet develop histolog-
ical evidence of glomerular disease by day 30. To investigate
the effect of high dietary protein on the course of renal disease,
a third group (N = 20) was given a 2% cholesterol diet for 30
days and then switched to a 2% cholesterol-high protein diet (50
g casein/l00 g diet; HCHP) for 40 days. A fourth group of
animals (N = 5) was maintained on a high protein diet (50 g
casein/100 g diet) for 70 days. To evaluate the effect of hemo-
lysis, six OP's were given a normal diet and injected with
acetylphenylhydrazine (APH) 30 mg/kg i.p. every other day for
40 days starting at day 30 to induce hemolysis [24]. The
compositions of the various diets are listed in Table 1. Ascorbic
acid was added to the water in the recommended amounts. All
animals had free access to food and water and were weighed
periodically.
C and HC animals were followed for up to 70 days. At each
of days 5, 10 and 30 three C and five HC GP's were selected for
detailed biochemical evaluation. One animal from C and five
animals from HC at day 5, two GP's from C and five from HC
at day 10, and three GP's from C and five from HC at day 30
were evaluated histochemically and morphologically. The bio-
chemical tests included urinalysis, serum free and total choles-
terol (FC and TC), serum triglyceride (TG), serum total phos-
pholipid (TPL), high density lipoprotein-cholesterol (HDL-C),
lipoprotein electrophoresis, serum lipoprotein-X (LP-X), serum
creatinine (Cr) and urea (BUN), liver function tests (SGOT,
direct and indirect bilirubin, total serum protein and protein
electrophoresis), serum electrolyte and renal cortical lipid anal-
ysis. Pathological examination included histopathology of the
kidneys and liver, renal histochemistry [oil red O(ORO) and
alpha-naphthyl acetate for nonspecific esterase (NSE)] and
semi-quantitative morphological evaluation of glomerular me-
sangia. All animals had hemoglobin and white count determi-
nations at the time of biochemical testing. The remaining
animals underwent the same testing at day 70. In addition four
OP's from C and six from HC had 2 twenty-four-hour urinary
protein and creatinine clearance (Ccr) determinations just prior
to day 70. The rate of de novo renal cholesterol synthesis was
determined in several animals from both C and HC at this time.
Renal immunohistochemistry and electron microscopy (EM)
were done in selected OP's (day 70).
The APH animals had hematological testing, serum lipid
determinations, liver function tests, serum Cr and BUN mea-
surements, urinalysis and renal histology and histochemistry at
day 70.
The HP and HCHP groups were followed for 70 days, at
which time the GP's were evaluated in exactly the same way as
the C and HC animals were (at day 70), including repeat 24-hour
urinary protein and Ccr determinations in four HP and six
HCHP animals. All animals were sacrificed under anesthesia by
exsanguination.
Analysis of renal cortical lipid
Lipids were extracted from the kidney homogenate according
to Folch et al [25]. FC, phospholipids (PL) and esterified
cholesterol (CE) were separated by thin layer chromatography
[26, 27]. PL were quantitated by the procedure of Turner and
Rouser 1126]. FC and CE were estimated by a modified Lieber-
mann-Burchard reaction [28].
Rate of de novo renal cholesterol synthesis
The rate of de novo cholesterol synthesis was determined by
both the tritiated water method [29] (3 GP's from HC and 2 from
C) and the estimation of 3-hydroxy-3 methyiglutaryl coenzyme
A (HMG-C0A) reductase activity [30] (5 animals from HC and
3 from C).
Pathology and histochemistry
Tissue removed for histological examination was fixed in 10%
buffered formalin. Liver and part of the kidney were embedded
in paraffin. One or two sections of kidney were fixed in
Karnovsky's fixative (buffered formalin-glutaraldehyde) and
embedded in polyglycol methacrylate (Polysciences Inc., War-
rington, Pennsylvania, USA). From paraffin-embedded tissue 3
micron sections were cut and stained with hematoxylin and
eosin (HE) and, in the case of the kidneys, with periodic
acid-Schiff reagent (PAS) and von Kossa for calcium. The
methacrylate-embedded sections were cut at 1 micron and
stained with HE, periodic acid-silver methenamine (PASM) and
Prussian blue for iron.
Renal cortex taken for EM was diced into 1 mm3 cubes, fixed
in phosphate-buffered 2.5% glutaraldehyde (Sorensen's solu-
tion) and embedded in Epon-Araldite (Polysciences Inc.). Ui-
trathin sections were cut with diamond knives, stained with
lead citrate and uranyl acetate and examined with a Zeiss EM
109 electron microscope.
For histochemistry and immunohistochemistry renal cortex
was snap-frozen in liquid nitrogen-cooled isopentane. Six mi-
cron sections were cut on a cryostat and stained for nonspecific
esterase (NSE) by the method of Yam, Li and Crosby [31]. For
oil red 0 (ORO) staining (for neutral lipid) formalin-fixed renal
cortex was frozen in a cryostat and 6 micron sections were
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used. Snap frozen 6 micron sections of renal cortex were
stained with commercially obtained FITC-conjugated goat-anti-
GP IgG antiserum (Cappell, Cochranville, Pennsylvania, USA).
To evaluate the degree of mesangial expansion, the semiquan-
titative method employed by Bank et a! [32] was used. Coded
methacrylate-embedded PASM-stained sections of renal cortex
were examined by one of the investigators (A.B.M.) without
knowledge of the group from which each individual kidney
came. In every case SO glomeruli were evaluated, and each was
graded 0 to 3 + according to the degree of mesangial expnnsion.
Grade 0 was no mesangial increase. Grade 1+ applied to
glomeruli showing a mild increase in mesangial matrix that
appeared to be twice that of a normal glomerulus. The increase
could be diffuse or localized to one lobule. In grade 2± change
the increase was seen in two lobules or was diffuse in which the
amount of mesangium appeared to be triple that of a normal
glomerulus. Grade 3+ was reserved for glomeruli exhibiting
either three or more expanded lobules or a diffuse increase in
mesangium at least four times normal. Each section was eval-
uated twice to check reproducibility. For each GP a score
representing the sum of grades was obtained.
The NSE index for each animal was the mean number of
intraglomerular NSE positive cells per glomerulus. The number
of glomeruli per animal evaluated for NSE index varied from 21
to 74.
Other tests
Serum FC and TC, serum TG, serum TL, lipoprotein elec-
trophoresis, Cr, BUN, SGOT, indirect and direct bilirubin,
serum protein electrophoresis, serum electrolytes, serum cal-
cium and phosphate, hemoglobin, white cell count and differen-
tial, urinalysis, 24-hour urinary protein and CCr were deter-
mined by standard hospital laboratory procedures. Plasma
LP-X at day 70 was determined qualitatively using the electro-
phoretic method of Neubeck and Seidel [33]. The heparin/
manganese chloride precipitation method was used to deter-
mine serum HDL-C concentration [341. Although LP-X may be
measured with HDL-C and theoretically lead to spuriously high
values for HDL-C, the serum concentration of LP-X is rela-
tively small compared to HDL-C, and for practical purposes
does not contribute significantly to the measured HDL-C level.
Statistics
Student's 1-test (two tailed) was used in situations where only
the means of two groups were being compared. When more
than two groups were being evaluated simultaneously, one way
analysis of variance (ANOVA) with the Bonferroni test [35] was
employed. Correlations were determined by multiple linear
regression analysis.
Results
General
Over the 70 day period C and HP animals showed very
similar weight gains (C = 387 51.9 g, HP = 367 42.1 g).
Both HC and HCHP GP's gained significantly less weight than
their respective controls (HC = 209.2 62.7 g, HCHP = 115.5
37.5 g; P < 0.001). The difference between the HC and
HCHP mean weight gains was significant (P <0.01). Although
the mean kidney weight of HP (3.0 0.3 g) was higher than C
(2.2 0.4 g), HC (2.2 0.3 g) and HCHP (2.5 0.3 g) the
differences were not significant. HC and HCHP animals devel-
oped a hemolytic anemia that became apparent after day 30 and
was more profound in HCHP which probably accounts for the
increased mortality in HCHP (40%) compared to I-IC (10%). No
C or HP animals died before day 70. All GP's that died prior to
the end of the experiment were excluded from the study.
At day 70 there was significant enlargement and marked fatty
change in the livers of both HC (weight 59.5 4.5g) and HCHP
(46.8 9.3 g) compared to their respective controls (P <0.01).
Both HC and HCHP animals had abnormal liver function tests.
Both groups showed elevated direct (HC = 0.30 0.2, HCHP
= 0.70 0.5 mg/dl) and indirect (HC = 0.12 0.5, HCHP =
0.50 0.3 mgfdl) bilirubins, total serum protein (HC = 5.4
0.2, HCHP 5.3 0.2 gldl) and SGOT (HC = 510 30, HCHP
= 510 10 lU/liter) compared to the C and HP controls (direct
bilirubin: C = 0.09 0.02, HP = 0.17 0.05 mgldl, indirect
bilirubin: C = 0.09 0.01, HP = 0.09 0.02 mgldl, serum
protein: C = 5.0 0.05, HP = 5.0 0.1 gIdl, SGOT: C = 117.3
3.9, HP 209 15 lU/liter). All groups had normal serum
albumin. The difference between C and HC with respect to
SGOT was significant (P < 0.01). Except for indirect bilirubin
(P < 0.0!), there were no significant differences between HC
and HCHP with respect to liver function tests. Splenomegaly
was observed in both HC and HCHP GP's.
All animals showed normal serum calcium and phosphate
levels.
Serum lipids
Table 2 shows total serum cholesterol (TC), relative amount
(percent) of free cholesterol (FC), HDL-C, triglyceride (TG)
and total serum phospholipid (TPL) at 5, 10, 30 and 70 days.
Baseline values for all animals were for practical purposes those
obtained for the C group at day 5. At days 5, 10, 30 and 70 TC
was considerably raised in HC. The proportion (%) of FC was
raised significantly at day 30 in HC. Although this parameter
was higher in HC than C at day 70, the difference was not
significant (ANOVA with Bonferroni). The HDL-C level was
significantly higher in HC compared to C at days 10, 30 and 70.
TPL levels in HC were significantly higher than those in C at
days 30 and 70.
At day 70 HCHP animals showed significantly higher serum
TC and TPL levels than did HC ones (Table 2). Serum HDL-C
and proportion of FC were similar in HC and HCHP at the end
of the experimental period. TG levels were similar in all groups.
LP-X was qualitatively detected at day 70 in both HC and
HCHP animals but not in controls. No attempt was made to
quantitate the levels of this lipoprotein. However a minimum
concentration of 5 to 10 mg/dl is necessary for the electropho-
retic detection of LP-X in plasma [33].
Renal function tests
Cr was normal in all groups over the entire experimental
period. No significant differences between the groups were
noted in Ccr at day 70. Quantitative urinary protein excretion
was elevated in HC (22.! 7.2 mg/24 hr) and HCHP (57.9
10.3 mg124 hr)compared to the controls (C = 6.4 2.3 mg/24
hr, HP = 13.7 6.3 mg/24 hr) at day 70. HCHP animals
excreted significantly more protein than did FTC ones (P < 0.01)
and had a higher degree of hematuria (4+ vs. 1+). Qualitative
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Table 2. Serum lipids at days 5, 10, 30 and 70
Parameter Group
Day
5 10 30 70
Total cholesterol mg/dl C
HP
HC
HCHP
35.0 3.6 (3)
—
142 33
—
36.0 6.1 (3)
—
216 48
—
35.0 3.6 (3)
—
250 23
—
42.2 4.7 (9)
50±14(9)
278 83 (11)"
373 96 (12)"
% Free cholesterol
High density lipoprotein.
C
HP
HC
HCHP
C
33 5 (6)
—
30 4 (6)
—
7.5 1.5
—
—
—
—
6.5 1.6
27 4 (6)
—
40 3 (6)
—
6.0 1.0
30 5 (6)
31±12(6)
41 6 (6)
46±12(6)
6.0 2.0 (4)
cholesterol mg/dl HP
HC
HCHP
6.0 1.0
—
9.8 l.6c
—
—
18.8 94d
—
6.0 3.0 (4)
80.0 20.0 (6)b
68.0 23.0 (6)"
Triglyceride mg/dl C
HP
HC
HCHP
73 32 (6)
62 23 (6)
—
—
—
—
—
72 24 (6)
—
68 23 (6)
—
65 15 (6)
71±12(6)
61 9 (6)
60±29(6)
Total phospholipid mg/dl C
HP
HC
HCHP
60.0 10.0
—
65 19
65.0 11.5
—
71 21
—
62.8 14.8
—
133 34C
—
65.0 4.1 (4)
72±10
315 50 (6)b
475 79 (6)b
The number of animals in each group is 5 except where indicated by a number in parentheses.
Abbreviations are: C, group on normal diet; HC, group on 2% cholesterol diet; HP, group on high protein diet; HCHP, group on 2% cholesterol-
high protein diet.
a p < 0.001 C vs. HC (Student's f-test)
b p < 0.017 C vs. HC, HC vs. HCHP (ANOVA with Bonferroni)
P < 0.01 C vs. HC, (Student's f-test)
"P < 0.025 C vs. HC (Student's f-test)
P < 0.005 C vs. HC (Student's t-test)
Table 3. Analysis of renal cortical lipid at days 5, 10, 30 and 70
Parameter Group
Day
5 10 30 70
Total cholesterol C 2.9 0.5 3.0 0.6 3.1 0.5 3.0 0.5 (4)
pg/mg protein HP
HC
HCHP
—
3.0 0.7
—
—
3.5 0.4
—
—
4.0 1.0
—
4.0 1.1
5.4 1.9 (6)
7.0 2.0 (6)
Free cholesterol g/ C 2.6 0.6 2.6 0.7 2.8 1.0 2.9 0.8 (4)
mgprotein HP
HC
HCHP
—
2.7 0.3
—
—
3.1 0.6
—
—
3.2 1.1
—
3.5 1.2
3.9 1.4 (6)
5.5 1.7 (6)
Cholesteryl ester % C
HP
HC
HCHP
10 3
—
10 4
—
10 5
—
11 6
—
10 5
—
21 10
—
10 5 (4)
10±4
26 11 (6)
21±6(6)
Phospholipid ag/mg C 19.7 6.5 20.0 6.1 20.2 7.0 22.3 4.1 (4)
protein HP
HC
HCHP
20.0 7.1
—
—
23.0 7.0
—
—
24.0 7.7
—
24.6 9.0
29.0 6.2 (6)
31.0 7.0 (6)
The number of animals in each group is 5, except where indicated by a number in brackets. Abbreviations are: C, group on normal diet; HP,
group on high protein diet (50% casein); HC, group on 2% cholesterol diet; HCHP, group on 2% cholesterol-high protein diet.
a P < 0.017 C vs. HC (ANOVA with Bonferroni)
urinalysis showed no protein excretion in either group at day various groups at 5, 10, 30 and 70 days. Percent CE was
30. significantly higher in HC animals than in C ones at day 70 (P <
0.017). The TC, FC and PL levels were higher at days 10, 30 and
Renal cortical lipid analysis and de novo cholesterol 70 in HC than in C but the differences were not significant.
synthesis rate Although the levels of TC, FC and PL were higher in HCHPthan in HC at day 70 the differences were not significant.
Table 3 depicts the TC, FC, percent cholesteryl ester (%CE) Percent CE was similar in both HC and HCHP. There was good
and phospholipid (PL) extracted from renal cortices of the correlation between tissue TC and serum TC (r = 0.776, P <
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Fig. 1. Glomerular histology at day 70 of control (C), high cholesterol (HC) and high cholesterol-high protein (HCHP) guinea pigs. (A) C guinea
pig. The glomerulus shows normal cellularity and mesangium (Hematoxylin and Eosin x 400); (B) HC guinea pig. The glomerulus is hypercellular
and the mesangium is expanded (grade 2+). Some cells within the tuft contain large, clear cytoplasmic vacuoles (arrowheads). (PASM x 400); (C)
HCHP guinea pig. There is considerable mesangial expansion (grade 3+). (PASM x 400).
0.001) and between tissue TC and urinary protein (r = 0.755, P
<0.001) (control and test animals considered together).
The rate of cholesterol synthesis by the kidney was markedly
reduced in the HC guinea pigs by both methods of determina-
tion [HMG-CoA reductase: C = 40.8 2.7 pmollmgfmin (N
3), FTC = 24.4 2.7 pmol/mg/min (N = 5); 3H20: C = 82.9
6.3 nmol/glhr (N = 2), HC = 18.5 3.6 nmol/g/hr (N = 3)1 (P
< 0.001). Thus the increased cholesterol content of the HC
kidneys was not due to increased local synthesis.
Renal histology, histochemistry, immunofluorescence and EM
Histological sections of C kidney at all time periods demon-
strated normal appearing glomeruli without any tubular, inter-
stitial or vascular changes (Fig. 1). HP kidneys were very
similar except for somewhat enlarged glomeruli.
HC kidneys at days 5 and 10 appeared histologically normal.
At day 30 variable increase in mesangial matrix with mesangial
hypercellularity was observed. Tubules, interstitium and arter-
ies showed no abnormalities. At day 70 quite pronounced
changes were observed in HC kidneys. Glomeruli showed
variably increased mesangial matrix. Both mesangial and endo-
capillary cellularity were increased (Fig. 1). The process was
quite variable in that in some glomeruli the changes were
pronounced whereas in others the alterations were minimal or
mild. Within the glomeruli some of the endocapillary cells
contained varying numbers of clear vacuoles (Fig. 1). No
hyaline was seen. Epithelial cells did not appear altered by light
microscopy. No crescents were seen. Tubules and interstitium
were normal histologically. Some arterial endothelial cells
showed cytoplasmic vacuoles. Otherwise arteries showed no
a
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Fig. 2. Hypercholesterolemic guinea pig at day 70. Neutral lipid is
present in the glomeruli as well as in an afferent arteriole (arrowhead).
(Oil red 0 x 250).
significant abnormalities. Extramedullary hematopoiesis was
noted in occasional glomeruli of some HC guinea pigs. Iron was
detected in tubules but not in glomeruli of HC.
HCHP kidneys demonstrated the same morphological changes
as the HC ones. The glomerular alterations appeared more
pronounced in the HCHP animals (Fig. 1). Extramedullary
hematopoiesis was also seen in occasional tubules in HCHP
GP's. The von Kossa stain for calcium was negative in all
kidneys examined.
Direct immunofluorescence was negative for IgG in kidneys
from all groups.
Histochemistry demonstrated ORO positive droplets pre-
dominantly in glomeruli but also focally in tubules and arteriolar
walls in HC and HCHP animals only (Fig. 2). This was most
pronounced at day 70. Glomerular lipid was first detected in
small amounts in some HC and HCHP animals at day 5. At day
30 all HC animals showed glomerular lipid with very focal
deposits in tubules and arterioles. No significant lipid deposi-
tion was seen in C or HP animals at any time.
Cells demonstrating moderate to strong diffuse cytoplasmic
staining for NSE were noted in glomeruli in the kidneys of all
groups (Fig. 3). In C and HP animals the number of these cells
was quite small. In HC the number of NSE positive (NSE+)
intraglomerular cells appeared to increase over time. While the
numbers of these cells at days 5, 10, and 30 did not appear
greater than normal in HC animals, the counts for both HC and
HCHP GP's were substantially increased at day 70. Some of the
NSE+ cells at day 70 contained cytoplasmic vacuoles.
Electron microscopic examination was done on some day 70
animals from all groups. The important changes noted in HC
and HCHP glomeruli compared to control ones were: (1) the
presence of varying numbers of clear cytoplasmic vacuoles in
endothelial, intracapillary mononuclear and some mesangial
cells (Fig. 4); (2) the increased number of cells in the mesangium
and the expanded mesangial matrix; and (3) focal fusion of foot
processes in HC and HCHP but not in C or HP. No electron
dense deposits were observed in any of the glomeruli examined.
Within many of the clear cytoplasmic vacuoles were electron
dense membranous figures. No extracellular lipid was seen in
Fig. 3. Hypercholesterolemic guinea pig at day 70. Several intraglo-
merular cells with diffuse cytoplasmic staining for nonspecific esterase
(NSE) (arrowheads) are present. Tubular cells also stain for NSE.
(alpha-naphthyl acetate x 250).
any of the HC glomeruli examined. Most of the intracapillary
mononuclear cells had the cytoplasmic characteristics of mono-
cytes with numerous cytoplasmic vesicles, some lysosomes,
scattered rough endoplasmic reticulum and an inconspicuous
Golgi apparatus. Some intracapillary mononuclear cells lacked
vesicles and lysosomes.
Quantitative morphology
The results for glomerular scoring and NSE index are pre-
sented in Table 4. There was a significant expansion in the
mesangial matrix beginning at day 30 in HC (P < 0.05), and this
process increased over the next forty days (P < 0.017). The
degree of mesangial expansion at day 70 was significantly higher
in HCHP animals than in HC ones (P < 0.01). There were no
significant differences between the NSE indices of HC and C
GP's at days 10 and 30. However, at day 70, both the HC and
HCHP groups showed a significant increase in NSE index (P <
0.0 17). The NSE index of the HCHP group was higher than that
of the HC one but the difference was not significant. The NSE
index showed good correlation with cortical TC (r =0.698, P <
0.001). Although the degree of mesangial expansion correlated
individually with serum TC (r 0.828, P < 0.001), cortical TC
(r = 0.823, P < 0.001), percent CE (r = 0.527, P < 0.001) and
NSE index (r = 0.794, P < 0.001), with multiple regression
analysis none of these correlations were significant because of
the strong interrelationships between the variables. The level of
proteinuria correlated individually with cortical TC (r 0.756,
P < 0.001), mesangial expansion (r = 0.749, P < 0.001) and
NSE index (r = 0.518, P < 0.05). Since the latter three
parameters were closely correlated (r =0.875, P < 0.001), none
of these factors showed significant independent correlation with
urinary protein by multiple linear regression analysis. (Control
and test animals were considered together in the regression
analyses.)
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Fig. 4. Hypercholesterolemic guinea pig at day 70. Two intracapillary cells (IC) contain a few clear vacuoles (some indicated by arrows) without
limiting membranes. Similar vacuoles are present in an endothelial cell (EC). Note the electron dense and membranous material (arrowheads)
within some of the vacuoles. (x 6500).
Table 4. Morphometric results for the 2 groups at days ba, 30 and 70
Parameter Group
Day
10 30 70
Mean mesangial score
NSE indexb
C
HP
HC
HCHP
C
HP
HC
HCHP
1.2 1.8 (6)
—
4.0 3.9 (10)
—
0.2 (1)
—
0.3 (5)
—
11.3 5.9 (3)
—
42,4 19.4(5)c
—
0.1 0.1 (3)
—
0.4 0.3 (5)
—
14.5 8.2 (10)
20.5 12.5 (6)
70.1 30.6 (1l'
101.3 18.3 (11'
0.2 0.1 (7)
0.4±0.1(4)
1.3 0.8 (6)
1.9 0.6 (6)C
The numbers in brackets are the number of animals evaluated in each group. Abbreviations are: C, groups on normal diet; HP, groups on high
protein diet; HC, groups on 2% cholesterol diet; HCHP, group on 2% cholesterol-high protein diet,
a Results from days 5 and 10 were combined because there was no significant difference between them.b Mean number of NSE positive cells per glomerulus
P < 0.05 C vs. HC (Student's t-test)
"P < 0.010 C vs. HC, HC vs. HCHP (ANOVA with Bonferroni)
P < 0.017 C vs. HC, C vs. HCHP (ANOVA with Bonferroni)
Findings in guinea pigs given APH
These animals developed a milder hemolytic anemia than did
HC ones and like the HC animals did not gain as much weight
as controls (APH = 172 50, HC = 209 63, C = 387 52).
The indirect biirubin in APH animals was very similar to that
for HC, suggesting that the degree of hemolysis may have been
at least similar to that of HC. Other hepatic and renal function
tests were normal in these animals. Histologically the kidneys
from the APH animals were indistinguishable from the C ones.
Staining with Prussian blue demonstrated iron in tubules but not
in glomeruli in the APH kidneys.
Discussion
In the present experiment feeding GP's a 2% cholesterol diet
resulted in marked hypercholesterolemia and significant gb-
S a.: -
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merular disease characterized by lipid accumulation in glomer-
uli, glomerular hypercellularity, increased mesangial matrix,
proteinuria and mild hematuria similar to that produced with a
1% cholesterol diet by French, Yamanaka and Ostwald [3].
Although the close relationship between serum lipid levels,
glomerular lipid accumulation and glomerular disease strongly
suggests a role for lipid in the pathogenesis of the renal disease,
the possibility that the glomerular lipid accumulation was a
secondary phenomenon cannot be summarily dismissed and
other pathogenetic possibilities must be considered.
The HC animals develop a hemolytic anemia shortly after the
time (day 30) that significant mesangial expansion is first
demonstrable suggesting that the glomerular lesion can develop
independently of the hemolytic anemia. Whether the hemolytic
anemia contributes to the progression of the lesion is uncertain.
Although the anemia in the APH group was milder than that in
HC, the close similarity between the raised indirect bilirubin
levels in the two groups suggests that the degree of hemolysis
may have been the same in them, the difference in hemoglobin
levels being accounted for by decreased erythropoeisis as
reflected by the low reticulocyte count in HC (T. Al-Shebeb,
unpublished observations). This suggests that hemolysis per se
is not a significant factor in the pathogenesis of glomerular
disease in hypercholesterolemic GP's. Although unlikely in
view of the fact that hemolytic anemia is not associated with
glomerular lesions, the possibility that the hemolytic anemia
may indirectly contribute to the development of the glomerulo-
sclerosis cannot be excluded.
HC animals gained significantly less weight than control
animals and may have been more susceptible to infection which
could have resulted in infection-related immune complex gb-
merubonephritis (GN) as has been reported previously [36].
Infections were not detected in HC animals. The negative IF
and the failure to detect deposits by EM tend to rule out an
immune complex mechanism in the present study. The failure
of HC animals to gain as much weight as C animals is probably
related to the anemia in HC as has been suggested by others
[37]. This is supported by the observations that HC animals
experience weight gains similar to control GP's prior to the
development of anemia and that APH-induced anemic GP's on
a normal diet experience a similar failure to thrive as HC GP's.
The possibility that the failure of HC GP's to gain as much
weight as controls may have contributed to the pathogenesis of
gbomerular disease must be considered. While this cannot be
excluded, it is unlikely since APH-treated animals which showed
weight gains similar to those of HC GP's did not develop
glomerular lesions.
HC GP's develop fatty livers and have abnormal liver func-
tion tests. Since various renal abnormalities such as immune
complex glomerulonephritis, hepatorenal syndrome and gb-
meruloscierosis have been associated with various liver dis-
eases [11, 38, 39] consideration must be given to the possibility
that the glomerular disease in HC GP's is liver related. This
seems quite unlikely in that there was no evidence of either
immune complex deposition in glomeruli or renal failure (as in
the hepatorenal syndrome). Glomerulosclerosis has been re-
ported in obstructive liver disease [11] which was not present in
HC animals.
The increase in plasma FC in HC animals was due to both an
increased intake and modestly (about 20%) decreased LCAT
activity (T. Al-Shebeb and I. Frohlich, unpublished observa-
tions). The lipoprotein changes in HC GP's were similar to
those published previously [18]. These included a marked
increase in HDL-C, likely caused by the accumulation of
cholesterol-rich HDL-particles and the appearance of LP-X in
the serum of HC animals. Renal cortical FC was raised in HC
animals at all times but the differences between HC and C were
not statistically significant. The discrepancy between the tissue
and plasma FC levels in the HC group may be the result of
significant tissue conversion of FC to CE by renal acyl CoA:
cholesterol acyltransferase (ACAT). The significantly raised
percentage CE in HC renal cortex and the demonstration of
considerable ORO positive material (probably CE since ORO
does not stain FC [40]) in HC glomeruli and vessels is consistent
with this proposal.
Although cortical TC in HC was higher than in C, the
difference was not significant. Much of the increase in tissue TC
appeared to be accounted for by raised levels of CE, which is
mostly demonstrable in gbomeruli and vessels. As these struc-
tures constitute a minor fraction of total cortical volume, a
significant rise in CE may not be reflected to the same degree in
the level of cortical TC. It is also possible that with a larger
number of animals and/or a longer experimental period, signif-
icant differences in cortical TC between HC and C GP's would
be detected.
Significantly increased intraglomerular monocytic infiltration
was detected in HC animals. This phenomenon has been
observed in a number of human and experimental immunolog-
ically-mediated glomerulonephridites [41—45] and experimental
evidence indicating a role for these cells in the pathogenesis of
some forms of glomerulonephritis has been presented [46, 47].
However, their participation in nonimmunologically-mediated
glomerular disease has not been previously documented. Al-
though the design of the present experiment precluded the
presentation of conclusive evidence, the results do suggest a
role for these cells in the development of the glomerular lesion.
The demonstration that monocytes secrete a factor (or factors)
stimulating mesangial cell proliferation [48, 49] supports this
concept.
The monocytic infiltration may not completely account for
the increase of the mesangium, since at day 30 there was a
significant difference in the degree of mesangial expansion
between HC and C GP's, but no significant difference in the
degree of intragbomerular monocyte infiltration (although the
NSE index of HC was higher than that of C). This suggests that
renal lipid accumulation which was increased by day 30 in HC
may have directly stimulated mesangial expansion. The good
correlation between serum and tissue TC and between serum
TC and mesangial expansion support this. The work of Grond,
Weening and Elema which suggested that deposition of lipopro-
tein macromolecules in the mesangium directly results in me-
sangial matrix increase and sclerosis [1] is consistent with this
concept.
In view of the correlation between urinary protein and
mesangial expansion it was somewhat surprising that protein-
uria was not detected in HC GP's at day 30 when glomerular
lipid deposition was readily demonstrable and significant me-
sangial expansion was observed. However the possibility that
microalbuminuria was present cannot be excluded. The detec-
tion of overt proteinuria at around the same time as increased
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glomerular monocyte infiltration became apparent suggests that
glomerular monocyte infiltration may have played a role in the
development of proteinuria as has been reported in modified
nephrotoxic serum nephritis in rats [43].
The addition of casein to the diet of HC animals resulted in
significantly worse renal disease. Inasmuch as the serum j,hos-
phate and calcium of the HCHP and HP GP's were normal, it
appears unlikely that the high phosphorus content of casein
played a significant role in augmenting the renal disease; It is
more probable that the increased renal damage seen in HCHP
animals is related to the significantly raised serum TC which is
believed to be a result of increased cholesterol absorption [50]
resulting in decreased number of hepatic low density lipopro-
tein receptors [51] associated with protein feeding. In view of
the serum TC findings, it is surprising that, although renal
cortical lipids were higher in HCHP animals, these parameters
were not significantly different than those of HC GP's at day 70.
It is possible to speculate that our failure to observe significant
increases in cortical lipid may be due to the observation that
much of the increase in lipid content appears to occur in
glomeruli and vessels. These structures constitute only a small
fraction of the renal cortex and hence an appreciable change in
glomerular and vascular lipid content without a parallel rise in
the tubular cell content may not be reflected to the same degree
in total tissue lipid level. A longer experimental period may also
be required for significant changes to develop in the cortical
lipid content in HCHP animals.
HCHP GP's demonstrated a significant increase in mesangial
matrix compared to HC animals. Although neither the extent of
intraglomerular monocytic infiltration nor cortical lipid deposi-
tion were significantly higher in the HCHP group, it is possible
that both factors together resulted in the significant augmenta-
tion. Another possible mechanism that may have contributed to
this phenomenon is protein-induced hyperfusion mechanical
damage [1, 17]. Whether this mechanism played a significant
role in the development of the glomerular lesion is difficult to
determine since measurements relating to this parameter were
not done.
In recent years considerable evidence has been amassed
suggesting the participation of monocytes in the development of
atherosclerotic lesions in arteries [52, 53]. These cells are
believed to be involved in the phagocytosis and degradation of
lipid in atherosclerotic lesions [54, 551 and the secretion of a
growth factor that stimulates smooth muscle proliferation [53].
In this regard there is evidence suggesting that mesangial cells
are modified smooth muscle cells [56, 57]. In view of the recent
conceptual developments in atherosclerosis linking hyperlipo-
proteinemia, lipid deposition in arterial walls, monocytic infil-
tration and smooth muscle proliferation [53, 55] the close
relationship between hypercholesterolemia, glomerular lipid
accumulation, monocytic infiltration and glomerulosclerosis in
the HC GP, it does not appear unreasonable to speculate that
the glomerular lesion produced in this experiment represents
atherosclerosis at the capillary level.
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